|
C5ORF15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.587400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.560600E-01 |
| Normal-vs-Stage2 |
7.823200E-01 |
| Normal-vs-Stage3 |
8.224000E-02 |
| Normal-vs-Stage4 |
4.388400E-01 |
| Stage1-vs-Stage2 |
7.597600E-01 |
| Stage1-vs-Stage3 |
5.589900E-02 |
| Stage1-vs-Stage4 |
3.167400E-01 |
| Stage2-vs-Stage3 |
2.857400E-01 |
| Stage2-vs-Stage4 |
5.462400E-01 |
| Stage3-vs-Stage4 |
8.469400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.813000E-01 |
| Normal-vs-AfricanAmerican |
4.074000E-01 |
| Normal-vs-Asian |
5.354800E-01 |
| Caucasian-vs-AfricanAmerican |
5.464000E-01 |
| Caucasian-vs-Asian |
4.879800E-01 |
| AfricanAmerican-vs-Asian |
5.990000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.054200E-01 |
| Normal-vs-Female |
1.771440E-01 |
| Male-vs-Female |
1.696620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.488400E-01 |
| Normal-vs-Extreme_Weight |
8.805200E-01 |
| Normal-vs-Obese |
3.822000E-01 |
| Normal-vs-Extreme_Obese |
8.757600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.749000E-01 |
| Normal_Weight-vs-Obese |
2.690600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.021800E-01 |
| Extreme_Weight-vs-Obese |
3.827400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.348600E-01 |
| Obese-vs-Extreme_Obese |
8.068600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.185400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.022200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.173000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.651600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.920800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.774000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.498600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.000310E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.462400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.054800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.973800E-01 |
| Normal-VS-Type2 PRCC |
3.155600E-01 |
| Normal-VS-KIRP CIMP |
3.554200E-01 |
| Normal-VS-Unclassified PRCC |
1.049180E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.968400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.553800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.397800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.605800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.227800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.697210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.802400E-01 |
| Normal-vs-N1 |
1.013190E-01 |
| Normal-vs-N2 |
2.031400E-01 |
| N0-vs-N1 |
1.127800E-01 |
| N0-vs-N2 |
5.514800E-01 |
| N1-vs-N2 |
8.497200E-01 |
|
|
